Oncothyreon to Present at Rodman & Renshaw Global Investment Conference

SEATTLE, Sept. 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 16^th Annual Global Investment Conference in New York on Tuesday, Sept. 9, 2014 at 2:05 p.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com

SOURCE Oncothyreon Inc.